Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
250.25
-2.75 (-1.09%)
At close: Feb 22, 2026

EGX:CPCI Ratios and Metrics

Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
3,7882,676997637551539
Market Cap Growth
144.77%168.26%56.67%15.47%2.38%25.17%
Enterprise Value
3,9052,7401,128710475432
Last Close Price
253.63168.5555.8933.0425.2222.22
PE Ratio
8.136.034.056.563.334.33
PS Ratio
1.661.290.730.630.500.51
PB Ratio
3.722.561.200.940.690.77
P/TBV Ratio
3.722.561.200.940.700.77
P/FCF Ratio
15.2611.1821.3867.3515.983.89
P/OCF Ratio
10.927.073.797.1910.643.32
EV/Sales Ratio
1.711.320.830.710.430.41
EV/EBITDA Ratio
6.054.573.888.042.292.76
EV/EBIT Ratio
6.544.833.959.262.472.76
EV/FCF Ratio
15.7311.4524.1975.1413.763.12
Debt / Equity Ratio
0.170.210.280.240.07-
Debt / EBITDA Ratio
0.270.370.821.770.28-
Debt / FCF Ratio
0.720.935.0917.381.69-
Net Debt / Equity Ratio
0.120.050.080.04-0.07-0.21
Net Debt / EBITDA Ratio
0.180.080.240.28-0.26-0.94
Net Debt / FCF Ratio
0.470.211.482.63-1.55-1.06
Asset Turnover
1.171.170.990.840.991.03
Inventory Turnover
2.752.441.942.092.562.59
Quick Ratio
0.930.981.171.051.901.77
Current Ratio
1.641.832.252.213.082.56
Return on Equity (ROE)
49.98%47.23%32.54%13.17%22.13%18.31%
Return on Assets (ROA)
19.20%20.04%12.96%3.98%10.73%9.50%
Return on Invested Capital (ROIC)
40.96%43.88%27.75%8.08%21.94%21.11%
Return on Capital Employed (ROCE)
49.80%46.20%27.30%9.70%22.40%22.00%
Earnings Yield
12.33%16.58%24.67%15.25%30.06%23.08%
FCF Yield
6.55%8.94%4.68%1.49%6.26%25.73%
Dividend Yield
6.69%9.93%22.95%15.13%19.83%18.00%
Payout Ratio
60.24%49.76%34.75%103.84%45.37%62.53%
Total Shareholder Return
6.41%9.93%22.95%15.13%19.83%18.00%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.